Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
Roche wins cybersquatting case
Africa
Roche has defeated a cybersquatter in a dispute centring on 18 domain names that infringed trademarks owned by the pharmaceutical company.   11 August 2016
Pharming to acquire rights for Ruconest
Big Pharma
Pharming Group, a Netherlands based company, has agreed to buy the North American commercialisation rights to its drug Ruconest from Valeant Pharmaceuticals.   11 August 2016
Easing the path for green tech in India
Asia
Even if India moves towards a patent-unfriendly environment for green technologies, the pro-patent and pro-environment lobbies can coexist and meet their respective goals, argue Swarup Kumar and Jitesh Kumar of Remfry & Sagar.   11 August 2016
Americas
Amgen has entered into a global agreement with Advaxis, allowing for the development and commercialisation of ADXS-NEO, a preclinical cancer immunotherapy treatment.   10 August 2016
Americas
Teva has settled a dispute with 48 US states after it was found guilty of attempting to pursue ‘pay-for-delay’ agreements with generic drug makers.   10 August 2016
Americas
Shionogi and Concordia Pharmaceuticals sued Hi-Tech Pharmacal yesterday for allegedly infringing patents centring on the drug Ulesfia, an anti-parasite medication.   9 August 2016
Americas
NuScience, a US based nutritional supplement company, has asked a court to imprison two brothers who are at the centre of a trade secrets lawsuit.   9 August 2016
Americas
The US and China take very different approaches to the patentability of a range of inventions in the life sciences field, as Yu Guo of China Patent Agent reports.   9 August 2016
Americas
AstraZeneca has sued Mylan for allegedly infringing its patents covering the drug Faslodex.   8 August 2016
Americas
AbbVie has sued Amgen saying its proposed biosimilar for the Humira (adalimumab) drug infringes 61 patents.   8 August 2016